Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The risks of 'miracle' weight loss jabs such as Ozempic, Wegovy and Mounjaro have been laid bare by a landmark study ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...